The Experience Matters. Let us show you why.
Contact us today.
Bart Cobert gives his pharmacovigilance point of view on a recent paper on FDA approval timelines and drug safety issues.
Read MoreBart Cobert on the importance of publishing clinical trials data and implications on pharmacovigilance.
Read MoreThis is an interesting article looking at what PV will be in the year 2030.
Read MoreBart Cobert explores several important points to take from the still ongoing signal and safety issue with Renitidine recall.
Read MoreBart Cobert covers several issues involved in setting up the proposed "Safe Importation Plan" which aims to allow US consumers to get safe and cheaper drugs.
Read MoreAn overview covering a number of things to avoid doing when it comes to drug safety.
Read MoreBart Cobert explores the potential reasons for the differing regulatory actions from the different agencies.
Read MoreDr. Adele Mueller explores the strong patient safety and advocacy responsibility of nurses who work in the pharmaceutical industry.
Read MoreBart Cobert discusses the importance of clinical safety reporting. Not only is this a legal responsibility but also an ethical one.
Read MoreBart Cobert addresses the use of marijuana for medical purposes and the implications for Drug Safety.
Read MoreAs an industry leader in business process outsourcing, HCL Technologies delivers global, multi-channel engagement solutions. The Experience Matters. Let us show you why.
Contact UsPlease note: we are currently updating our website which will be live shortly.